Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Prednisolone treatment

PreclinicalSmall molecule

BBarz IVF Center for Infertility Treatment and Embryo Research

Prednisolone treatment is one of 2 small molecule programs targeting Prednisolone. It is currently in Preclinical.

1

Indications

1

Total Trials

0

Active Trials

1

Competitors

Pipeline

Status by Indication[3][1]

Indication

PrednisoloneCompleted

PrednisolonePreclinical

Completed

Competition

Competitive Landscape

1 competitor in Prednisolone

#DrugCompanyPhaseTrials

Emflaza

PPTC Therapeutics

Prednisolone treatment

BBarz IVF Center for Infertility Treatment and Embryo Research

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Prednisolone1 trial

Prednisolone Improves IVF Outcomes in Men With Anti-sperm Antibodies

Completed·BBarz IVF Center for Infertility Treatment and Embryo Research·N/A·NCT02935738·241 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Prednisolone treatment. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Prednisolone treatment compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Prednisolone treatment. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Barz IVF Center for Infertility Treatment and Embryo Research company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: BBarz IVF Center for Infertility Treatment and Embryo Research

Related News